Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Dr. George Murphy | The ReProgram

Steve Horvath on epigenetic clocks, age-reversal claims and organ-by-organ rejuvenation

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

In this podcast description, Steve Horvath discusses why epigenetic clocks differ, why dramatic age-reversal claims need scrutiny, and why routine clinical use is not yet here; the description notes that a cited vision study was in mice. [1]

  1. The description says different aging clocks can produce different results and that Horvath argues for transparent reporting across multiple clocks. [1]

  2. According to the description, Horvath sees promise in clinical use but says routine patient care is not there yet. [1]

  3. The description states that a cited vision-restoration study was preclinical mouse research, not evidence of whole-body age reversal in humans. [1]

Horvath on why many epigenetic clocks give different results

The description introduces Dr. Steve Horvath, Professor of Medicine and Director of Aging Biology Research at UCLA, as a geroscientist and biostatistician who developed the influential 2013 multi-tissue DNA methylation clock. A key takeaway is that different aging clocks can produce different results, and Horvath argues for transparent reporting across multiple clocks. The description does not say which clocks were compared or what the differences were. [1]

Age-reversal claims and clinical use: caution, not routine care yet

According to the description, dramatic age-reversal claims deserve scrutiny, and a younger test result needs meaningful interpretation. Horvath sees promise in clinical use while emphasizing that routine patient care is not there yet. The description also states that a cited study on reprogramming and vision restoration was preclinical mouse research, not evidence of whole-body age reversal in humans. [1]

Rejuvenation as prevention, pursued one organ at a time

The description links rejuvenation to prevention: the aim is to preserve health before disease develops. It says a realistic path may focus on individual organs rather than a single treatment for the entire body. The description frames the next challenge as connecting measurements to outcomes that matter to people, asking what changed, how reliably it was measured, and what it means for health and function. [1]

Context & limits

This explainer is based only on the video description. The video and transcript were not reviewed, so details of the discussion, comparisons and any numbers are unknown. The description is a promotional overview; its claims are attributed to the description and creator, not independently verified.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Can We Really Measure and Reverse Aging? | Steve Horvath
Quoted passages in the original language
Different aging clocks can produce different results
routine patient care is not there yet
preclinical mouse research, not evidence of whole-body

About this video

Creator description · original language

🎬 EPISODE OVERVIEW Can a younger clock score translate into better health? In Episode 30, I sit down with Dr. Steve Horvath to explore epigenetic clocks, biological-age claims, and his vision for rejuvenation. We discuss why there are so many clocks, what stands between research and patient care, prevention, and why progress may come one organ at a time. 👤 ABOUT THE SPEAKER Dr. Steve Horvath is Professor of Medicine and Director of Aging Biology Research at UCLA’s David Geffen School of Medicine. A geroscientist and biostatistician, he developed the influential 2013 multi-tissue DNA methylation clock. Lab profile: https://horvathaginglab.org/ 🔑 KEYWORDS Steve Horvath • Epigenetic Clocks • DNA Methylation • Biological Age • Rejuvenation • Prevention • Aging Biomarkers • Geroscience 📌 KEY TAKEAWAYS • Different aging clocks can produce different results. Horvath argues for transparent reporting across multiple clocks. • Dramatic age-reversal claims deserve scrutiny; a younger test result needs meaningful interpretation. • Horvath sees promise in clinical use, while emphasizing that routine patient care is not there yet. • Rejuvenation is connected to prevention: the aim is to preserve health before disease develops. • A realistic path may focus on individual organs rather than a single treatment for the entire body. 🎙️ THE REPROGRAM PERSPECTIVE Better measurement can sharpen the questions we ask about aging. The next challenge is connecting those measurements to outcomes that matter to people. Our focus: what changed, how reliably was it measured, and what does it mean for health and function? ⏱️ CHAPTERS 00:00 Can we measure and reverse aging? 00:51 Introducing Steve Horvath 01:40 Reinventing a research career 05:28 Why are there so many aging clocks? 07:51 Bringing clocks into clinical practice 09:16 Evaluating age-reversal claims 11:31 Rejuvenation and prevention 14:37 What does rejuvenation mean? 16:26 One organ at a time 18:36 Lifestyle, testing, and perspective 20:57 Closing thoughts 📝 NOTES AND REFERENCES Related papers featured in the edit: 1. Horvath S. DNA methylation age of human tissues and cell types. Genome Biology (2013). https://doi.org/10.1186/gb-2013-14-10-r115 2. Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics (2018). https://doi.org/10.1038/s41576-018-0004-3 3. Lu Y et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature (2020). https://doi.org/10.1038/s41586-020-2975-4 The Lu study is preclinical mouse research, not evidence of whole-body age reversal in humans. 💬 JOIN THE CONVERSATION What would convince you that an intervention truly rejuvenates: a younger clock score, better organ function, or both? *Subscribe to The ReProgram for longevity biology without the hype. https://www.youtube.com/@ReProgramPodcast* Mechanism over marketing. Evidence over anecdotes. Trade-offs over hype.

Dr. George Murphy | The ReProgram · 22 min · Source published: 2026-10-12

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…